Source link : https://newshealth.biz/health-news/teclistamab-alone-ups-previously-treated-myeloma-survival/
In the first phase 3 trial of teclistamab monotherapy, the bispecific antibody was associated with better PFS and OS than standard regimens in relapsed or refractory multiple myeloma. Medscape Medical News Source link : https://www.medscape.com/viewarticle/teclistamab-alone-ups-previously-treated-myeloma-survival-2026a1000i2u?src=rss Author : Publish date : 2026-05-31 21:55:00 Copyright for syndicated content belongs to the linked Source.
The post Teclistamab Alone Ups Previously Treated Myeloma Survival first appeared on News Health.
—-
Author : News Health
Publish date : 2026-05-31 21:55:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8